Apremilast (Otezla) effective in moderate to severe psoriasis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Apremilast (Otezla) Effective in Moderate to Severe Psoriasis." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/428387/all/Apremilast__Otezla__effective_in_moderate_to_severe_psoriasis.
Apremilast (Otezla) effective in moderate to severe psoriasis. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428387/all/Apremilast__Otezla__effective_in_moderate_to_severe_psoriasis. Accessed October 13, 2024.
Apremilast (Otezla) effective in moderate to severe psoriasis. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428387/all/Apremilast__Otezla__effective_in_moderate_to_severe_psoriasis
Apremilast (Otezla) Effective in Moderate to Severe Psoriasis [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428387/all/Apremilast__Otezla__effective_in_moderate_to_severe_psoriasis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Apremilast (Otezla) effective in moderate to severe psoriasis
ID - 428387
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/428387/all/Apremilast__Otezla__effective_in_moderate_to_severe_psoriasis
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -